These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 4994876

  • 1. [Pathogenesis and therapy of gout].
    Mertz DP.
    Med Klin; 1971 Apr 23; 66(17):623-6. PubMed ID: 4994876
    [No Abstract] [Full Text] [Related]

  • 2. Hyperuricemia and gout. Classification, complications and management.
    Boss GR, Seegmiller JE.
    N Engl J Med; 1979 Jun 28; 300(26):1459-68. PubMed ID: 221806
    [No Abstract] [Full Text] [Related]

  • 3. [Gout (pathogenesis and therapy)].
    Chirone E.
    Policlinico Prat; 1968 Feb 05; 75(6):177-87. PubMed ID: 5744779
    [No Abstract] [Full Text] [Related]

  • 4. Selected aspects of the aetiology, pathogenesis and treatment of disorders of purine metabolism.
    Boyle JA, Seegmiller JE.
    Mod Trends Rheumatol; 1971 Feb 05; 2():299-322. PubMed ID: 4949589
    [No Abstract] [Full Text] [Related]

  • 5. The physiologic approach to hyperuricemia.
    Rastegar A, Thier SO.
    N Engl J Med; 1972 Mar 02; 286(9):470-6. PubMed ID: 4550616
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gout and uric acid metabolism.
    Arthritis Rheum; 1970 Mar 02; 13(5):553-69. PubMed ID: 4922854
    [No Abstract] [Full Text] [Related]

  • 10. [Uricoeliminating or urico-inhibiting agents? Reasons for a choice].
    Cottin S, Prost A.
    Sem Hop; 1972 May 20; 48(24):1739-42. PubMed ID: 4340887
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Editorial: Therapy of gout nowadays (author's transl)].
    Mertz DP.
    Schweiz Rundsch Med Prax; 1974 Oct 08; 63(40):1185-7. PubMed ID: 4445089
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of gouty purine metabolism disorder with mercapto-pyrazolo-pyrimidine (thiopurinol)].
    Delbarre F, Auscher C, de Gery A, Brouilhet H, Olivier JL.
    Presse Med (1893); 1968 Dec 14; 76(49):2329. PubMed ID: 5737251
    [No Abstract] [Full Text] [Related]

  • 14. Milestones in the treatment of gout.
    Yü T, Yu TF.
    Am J Med; 1974 May 14; 56(5):676-85. PubMed ID: 4604776
    [No Abstract] [Full Text] [Related]

  • 15. [Preliminary clinical experiences with mercapto-pyrazolo-pyrimidine (thiopurinol) in the therapy of gout].
    Solazzi F, Cirla E, Tosi S.
    Reumatismo; 1971 May 14; 23(5):257-63. PubMed ID: 5164647
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Drug treatment of gout.
    Kelley WN, Wyngaarden JB.
    Semin Drug Treat; 1971 Sep 14; 1(2):119-47. PubMed ID: 4949305
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.